ZBIO · Zenas BioPharma, Inc. · Documents
$28.18
+1.47 (+5.50%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.87B
Shares
65.18M
Volume · Oct 20
549.03K
Avg daily vol (3M)
702.03K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Zenas BioPharma announced Phase 3 INDIGO open-label extension results for obexelimab on October 12, 2026, including a 12-month flare-free probability of 0.93 and a week-52 glucocorticoid toxicity score difference of -11.4 (p=0.021). | 2026-10-13 | 2026-10-12 | |
| Investor Event Transcript | — | 2026-09-29 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| S-3ASR | — | 2026-09-11 | — | |
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | 2026-08-12 | |
| 8-K | — | 2026-05-13 | 2026-05-11 | |
| 10-Q | — | 2026-05-13 | 2026-03-31 | |
| 8-K | — | 2026-03-31 | 2026-03-26 | |
| DEF 14A | — | 2026-03-16 | 2026-05-11 | |
| DEFA14A | — | 2026-03-16 | — | |
| 8-K | — | 2026-03-16 | — | |
| 10-K | — | 2026-03-16 | 2025-12-31 | |
| ARS | — | 2026-03-16 | 2025-12-31 | |
| 8-K | — | 2026-02-13 | 2026-02-10 | |
| 8-K | — | 2026-01-05 | — | |
| 8-K | — | 2025-12-15 | 2025-12-10 | |
| 8-K | — | 2025-11-12 | — | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| 8-K | — | 2025-10-27 | — | |
| S-3ASR | — | 2025-10-21 | — | |
| 8-K | — | 2025-10-08 | 2025-10-07 | |
| S-3ASR | — | 2025-10-08 | — | |
| 8-K | — | 2025-09-02 | — | |
| 8-K | — | 2025-08-12 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-06-12 | 2025-06-10 | |
| 8-K | — | 2025-06-04 | — | |
| 10-Q | — | 2025-05-15 | 2025-03-31 | |
| 8-K | — | 2025-05-15 | — | |
| DEF 14A | — | 2025-04-28 | 2025-06-10 | |
| DEFA14A | — | 2025-04-28 | — | |
| ARS | — | 2025-04-28 | 2024-12-31 | |
| 10-K | — | 2025-03-11 | 2024-12-31 | |
| 8-K | — | 2025-02-05 | — | |
| 8-K | — | 2024-12-02 | — | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-11-12 | — | |
| 8-K | — | 2024-09-16 | — | |
| S-1/A | — | 2024-09-06 | — | |
| S-1 | — | 2024-08-22 | — |
Showing 1–42 of 42 filings